China News Service, February 5th. According to Korea Broadcasting International (KBS), the Korean Central Pharmacist Review Committee stated on the 4th that based on the current clinical trial results, the use of AstraZeneca's new crown vaccine can be approved, but it is recommended that the special committee for vaccination in the future Continue to discuss whether we can vaccinate people over 65 years old.
The Korean Food and Drug Safety Agency said on the 5th that in order to consult on the safety and effectiveness of AstraZeneca's new crown vaccine, a meeting of the Central Pharmacist Review Committee was held in the afternoon of the 4th local time at the Osong Food and Drug Safety Office in Chungbuk.
At this meeting, the Central Pharmacist Review Committee determined that it is necessary to use AstraZeneca vaccine to prevent the new crown epidemic in Korea.
Based on the previous consultation results of the "New Coronary Vaccine Safety and Effectiveness Verification Advisory Group", the committee stated that based on the current clinical trial results, the use of AstraZeneca's new crown vaccine can be approved, but it is recommended that the vaccination committee continue to do so in the future. Vaccination for senior citizens over 65 years old will be discussed.
The Department of Food and Drug Safety stated that it will consider the previous "New Coronary Vaccine Safety and Effectiveness Verification Advisory Group" and the expert opinions received by the Central Pharmacist Review Committee consultation meeting, as well as the effectiveness and recommendations of the vaccine, and make a decision in the final verification committee Whether to approve the use of AstraZeneca's new crown vaccine.